BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED
162 results:

  • 1. Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies.
    Yang T; Liu J; Liu F; Lei J; Chen S; Ma Z; Ke P; Yang Q; Wen J; He Y; Duan J; Zeng X
    Front Immunol; 2023; 14():1294677. PubMed ID: 38235128
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification and validation of SLCO4C1 as a biological marker in hepatocellular carcinoma based on anoikis classification features.
    Wang T; Guo K; Yang S; Zhang D; Cui H; Yin J; Yuan S; Wang Y; Qi Y; Wu W
    Aging (Albany NY); 2024 Jan; 16(2):1440-1462. PubMed ID: 38226966
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic and predictive biomarkers in paediatric solid tumours.
    Glembocki AI; Somers GR
    Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Seven oxidative stress-related genes predict the prognosis of hepatocellular carcinoma.
    Miao C; He X; Chen G; Kahlert UD; Yao C; Shi W; Su D; Hu L; Zhang Z
    Aging (Albany NY); 2023 Dec; 15(24):15050-15063. PubMed ID: 38097352
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance.
    Banerjee D; Boboila S; Okochi S; Angelastro JM; Kadenhe-Chiweshe AV; Lopez G; Califano A; Connolly EP; Greene LA; Yamashiro DJ
    Cancer Res Commun; 2023 Dec; 3(12):2518-2530. PubMed ID: 38014922
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LINC02561 promotes metastasis in HCC via HIF1-α/NDRG1/UPF1 axis.
    Li SN; Li MX; Guo WW; Zhang LR; Ding YH; Wu XJ
    Gene; 2024 Feb; 896():148033. PubMed ID: 38013127
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targeted Degradation of XIAP is Sufficient and Specific to Induce Apoptosis in mycn-overexpressing High-risk Neuroblastoma.
    Choo Z; Koh X; Wong MRE; Ashokan RM; Ali Ahamed NSB; Kang C; Kuick CH; Chang KTE; Larisch S; Loh AHP; Chen ZX
    Cancer Res Commun; 2023 Nov; 3(11):2386-2399. PubMed ID: 37874199
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Adaptation of the Th-mycn Mouse Model of Neuroblastoma for Evaluation of Disseminated Disease.
    Rahavi SM; Aletaha M; Farrokhi A; Lorentzian A; Lange PF; Maxwell CA; Lim CJ; Reid GSD
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569447
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A TGF-β-dominant chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children.
    Xiang X; Hao Y; Cheng C; Hu H; Chen H; Tan J; Wang Y; Liu X; Peng B; Liao J; Wang J; Xie Y; Liu J; Chen S; Xu L; Xie W; Xue R; Kuang M; Xu Z; Jiang H; Peng S
    Hepatology; 2024 Mar; 79(3):650-665. PubMed ID: 37459556
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.
    Huang DQ; Tran A; Yeh ML; Yasuda S; Tsai PC; Huang CF; Dai CY; Ogawa E; Ishigami M; Ito T; Kozuka R; Enomoto M; Suzuki T; Yoshimaru Y; Preda CM; Marin RI; Sandra I; Tran S; Quek SXZ; Khine HHTW; Itokawa N; Atsukawa M; Uojima H; Watanabe T; Takahashi H; Inoue K; Maeda M; Hoang JK; Trinh L; Barnett S; Cheung R; Lim SG; Trinh HN; Chuang WL; Tanaka Y; Toyoda H; Yu ML; Nguyen MH
    Hepatology; 2023 Nov; 78(5):1558-1568. PubMed ID: 37184202
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Predicting the prognosis of hepatocellular carcinoma based on the interaction between pyroptosis, apoptosis, and necroptosis.
    Qian F; Kong W; Wang S; Wei K
    Clin Exp Med; 2023 Oct; 23(6):2087-2104. PubMed ID: 36271962
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma.
    Zou Z; Sun Y; Wang L; Ma S; Sun C; Zhou Y; Yang G
    Medicine (Baltimore); 2022 Aug; 101(32):e29645. PubMed ID: 35960100
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Neuroblastoma: Essential genetic pathways and current therapeutic options.
    Salemi F; Alam W; Hassani MS; Hashemi SZ; Jafari AA; Mirmoeeni SMS; Arbab M; Mortazavizadeh SMR; Khan H
    Eur J Pharmacol; 2022 Jul; 926():175030. PubMed ID: 35605657
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Normal and Neoplastic Growth Suppression by the Extended Myc Network.
    Prochownik EV; Wang H
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203395
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Infantile Stage M Neuroblastoma With 11q Deletion, Mimicking Stage MS.
    Yoshimoto Suzuki Y; Yamanaka J; Miyazaki O; Nozawa K; Ohira M; Kamijo T; Shichino H
    J Pediatr Hematol Oncol; 2022 Apr; 44(3):e779-e781. PubMed ID: 35001057
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Claudin-2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription.
    Wei M; Zhang Y; Yang X; Ma P; Li Y; Wu Y; Chen X; Deng X; Yang T; Mao X; Qiu L; Meng W; Zhang B; Wang Z; Han J
    Clin Transl Med; 2021 Dec; 11(12):e667. PubMed ID: 34965023
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Factors Associated with Recurrence of Hepatocellular Carcinoma in 197 Patients Following Transarterial Chemoembolization: A Retrospective Study from a Single Center.
    Zhang H; Zhao X; Yu W
    Med Sci Monit; 2021 Sep; 27():e929879. PubMed ID: 34531359
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MiR-188-3p and miR-133b Suppress Cell Proliferation in Human Hepatocellular Carcinoma via Post-Transcriptional Suppression of NDRG1.
    Luo Z; Fan Y; Liu X; Liu S; Kong X; Ding Z; Li Y; Wei L
    Technol Cancer Res Treat; 2021; 20():15330338211033074. PubMed ID: 34355586
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network.
    Wang Z; Zhang S
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212175
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids.
    Zhao Y; Li ZX; Zhu YJ; Fu J; Zhao XF; Zhang YN; Wang S; Wu JM; Wang KT; Wu R; Sui CJ; Shen SY; Wu X; Wang HY; Gao D; Chen L
    Adv Sci (Weinh); 2021 Jun; 8(11):e2003897. PubMed ID: 34105295
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.